Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
9.22
-0.14 (-1.50%)
Jan 24, 2025, 4:00 PM EST - Market closed
Treace Medical Concepts Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for TMCI stock have an average target of 8.84, with a low estimate of 7.00 and a high estimate of 14.5. The average target predicts a decrease of -4.12% from the current stock price of 9.22.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for TMCI stock from 8 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 7 | 7 | 6 | 6 | 7 | 7 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 6 | 6 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +57.27% | Dec 31, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $7 → $8.4 | Hold | Maintains | $7 → $8.4 | -8.89% | Dec 18, 2024 |
| JP Morgan | JP Morgan | Hold Initiates $8 | Hold | Initiates | $8 | -13.23% | Dec 17, 2024 |
| Stifel | Stifel | Hold Maintains $7 → $8 | Hold | Maintains | $7 → $8 | -13.23% | Nov 6, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $7.5 → $6 | Hold | Maintains | $7.5 → $6 | -34.92% | Oct 14, 2024 |
Financial Forecast
Revenue This Year
211.94M
from 187.12M
Increased by 13.27%
Revenue Next Year
230.19M
from 211.94M
Increased by 8.61%
EPS This Year
-0.94
from -0.81
EPS Next Year
-0.77
from -0.94
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 219.6M | 240.6M | 275.1M | |
| Avg | 211.9M | 230.2M | 253.6M | |
| Low | 202.9M | 219.1M | 234.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 17.3% | 13.5% | 19.5% | |
| Avg | 13.3% | 8.6% | 10.2% | |
| Low | 8.4% | 3.4% | 2.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.96 | -0.74 | -0.64 |
| Avg | -0.94 | -0.77 | -0.69 |
| Low | -0.94 | -0.86 | -0.74 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.